EWA
MIRA icon

EverSource Wealth Advisors’s MIRA Pharmaceuticals MIRA Stock Holding History

EverSource Wealth Advisors’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-365
Closed -$496 – 4373
2025
Q3 		$496 Buy
+365
New +$530 ﹤0.01% 3952

Other funds holding MIRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

EverSource Wealth Advisors's MIRA Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of MIRA Pharmaceuticals (MIRA) in Q4 2025, closing a stake of 365 shares — an estimated $496 sold.

EverSource Wealth Advisors first reported a position in MIRA in Q3 2025 and held it in 1 quarter. The position peaked at $496 in Q3 2025. 25 funds tracked by Wall St. Rank hold MIRA as of Q4 2025.

  • EverSource Wealth Advisors reported no remaining MIRA Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 365 MIRA Pharmaceuticals shares in Q4 2025, an estimated $496.
  • EverSource Wealth Advisors first reported a position in MIRA Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • EverSource Wealth Advisors's MIRA Pharmaceuticals position peaked at $496 in Q3 2025.
  • 25 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.